COGA’s COVID-19 analytic sample

JM Jacquelyn L. Meyers
VM Vivia V. McCutcheon
KH Kristina A. Horne-Osipenko
LW Lawrence R. Waters
PB Peter Barr
GC Grace Chan
DC David B. Chorlian
EJ Emma C. Johnson
SK Sally I-Chun Kuo
JK John R. Kramer
DD Danielle M. Dick
SK Samuel Kuperman
CK Chella Kamarajan
GP Gayathri Pandey
DS Dzov Singman
SV Stacey Subbie-Saenz de Viteri
JS Jessica E. Salvatore
LB Laura J. Bierut
TF Tatiana Foroud
AG Alison Goate
VH Victor Hesselbrock
JN John Nurnberger
MP Martin H. Plaweck
MS Marc A. Schuckit
AA Arpana Agrawal
HE Howard J. Edenberg
KB Kathleen K. Bucholz
BP Bernice Porjesz
ask Ask a question
Favorite

In May 2020, shortly after the pandemic began and the data collection for the latest lifespan protocol had just begun, we added adapted versions of the CoRonavIruS Health Impact Survey (CRISIS) PhenX questionnaire [40] and the ABCD (Adolescent Brain Cognitive Development Study) COVID questionnaire [41] to the COGA assessment protocol to capture major COVID-19 related stressors, healthy coping activities, and changes in alcohol use/misuse since the onset of the pandemic in March 2020. While data collection is ongoing, as of July 22, 2022, questionnaire data had been obtained on 1654 participants. Genome-wide association data are available in 96.1% of this sample, and EEG assessments are available in 75.7% of the sample. Of those who completed the COVID-19 questionnaire, 61.8% were female, 79% were White, and the average age was 50.7 (Table (Table11).

Descriptive characteristics of COGA’s lifespan project COVID-19 sample, stratified by pre-pandemic AUD status.

aSignificantly different p < 0.001 from other groups.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A